Cargando…

2420. A Real-World Perspective on the Efficacy of Fosfomycin for Treatment of Multidrug-Resistant Pathogens Causing Urinary Tract Infections

BACKGROUND: Urinary tract infections (UTI) are the most common infection associated with multidrug-resistant (MDR) pathogens. With limited treatment options, there has been an increasing interest in the efficacy of fosfomycin (FOS); however, real-world clinical data are limited. Our objective was to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Babiker, Ahmed, Clarke, Lloyd, Shields, Ryan K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253212/ http://dx.doi.org/10.1093/ofid/ofy210.2073

Ejemplares similares

1528. A Real-World Perspective on Treatment of CRE UTIs With Oral Agents
por: Babiker, Ahmed, et al.
Publicado: (2018)

Fosfomycin in infections caused by multidrug-resistant Gram-negative pathogens
por: Ruiz Ramos, Jesús, et al.
Publicado: (2019)

Efficacy and Safety of Oral Fosfomycin-Trometamol in Male Urinary Tract Infections with Multidrug-Resistant Enterobacterales
por: Bouiller, Kévin, et al.
Publicado: (2022)

Oral and intravenous fosfomycin in complicated urinary tract infections
por: López-Montesinos, Inmaculada, et al.
Publicado: (2019)

Observation of D$_{1}$(2420)$^{+}$ and D$_{2}^{*}$(2460)$^{+}$
por: Bergfeld, T, et al.
Publicado: (1994)

2420. Analysis of Diagnostic Criteria for ECMO-Associated Pneumonia
por: England, Julie, et al.
Publicado: (2023)

Real-Life Comparison of Fosfomycin to Nitrofurantoin for the Treatment of Uncomplicated Lower Urinary Tract Infection in Women
por: Shafrir, Asher, et al.
Publicado: (2023)

Fosfomycin for management of persistent female lower urinary tract infection
por: Joob, Beuy, et al.
Publicado: (2018)

Oral and Intravenous Fosfomycin for the Treatment of Complicated Urinary Tract Infections
por: Zhanel, George G., et al.
Publicado: (2020)

Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial
por: Sojo-Dorado, Jesús, et al.
Publicado: (2022)

611. Fosfomycin Resistance of Multidrug-Resistant Escherichia coli and Mechanisms of Fosfomycin Resistance
por: Seok, Hyeri, et al.
Publicado: (2019)

In vitro effect of fosfomycin on multi-drug resistant gram-negative bacteria causing urinary tract infections
por: Gopichand, Pallam, et al.
Publicado: (2019)

In vitro Activity of Fosfomycin against Multidrug-Resistant Urinary and Nonurinary Gram-Negative Isolates
por: Behera, Bijayini, et al.
Publicado: (2018)

Oral fosfomycin for treatment of urinary tract infection: a retrospective cohort study
por: Matthews, Philippa C., et al.
Publicado: (2016)

Cost-Effectiveness Analysis of Fosfomycin for Treatment of Uncomplicated Urinary Tract Infections in Ontario
por: Perrault, Louise, et al.
Publicado: (2017)

Experience with fosfomycin in the treatment of complicated urinary tract infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae
por: Bielen, Luka, et al.
Publicado: (2019)

1417. Fosfomycin Use in the Treatment of Complicated Urinary Tract Infections at a Veterans Affairs Medical Center
por: Lee, Ryan, et al.
Publicado: (2021)

Oral fosfomycin for treatment of acute bacterial prostatitis caused by multidrug-resistant Enterobacterales
por: Burgos, Joaquin, et al.
Publicado: (2023)

A Comparative Study of Urinary Tests and Cultures for the Effectiveness of Fosfomycin in Catheter-Related Urinary Tract Infections
por: Jo, Jung Ki, et al.
Publicado: (2022)

Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled trial
por: Gágyor, Ildikó, et al.
Publicado: (2015)

Multiple-Dose Oral Fosfomycin for Treatment of Complicated Urinary Tract Infections in the Outpatient Setting
por: Derington, Catherine G, et al.
Publicado: (2020)

Pharmacokinetics of fosfomycin in patients with prophylactic treatment for recurrent Escherichia coli urinary tract infection
por: Kuiper, Sander G, et al.
Publicado: (2020)

2420 Examining characteristics of placebo effects on trauma-related insomnia in a suvorexant trial
por: Uweh, Kimberly
Publicado: (2018)

Use of fosfomycin combination therapy to treat multidrug-resistant urinary tract infection among paediatric surgical patients – a tertiary care centre experience
por: K.S., Shiju, et al.
Publicado: (2020)

PB2420: DEVELOPMENT AND VALIDATION OF THE PRACT MODEL FOR ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS ABOVE 60 YEARS OLD WITH HAEMATOLOGICAL MALIGNANCIES IN A REAL-WORLD STUDY
por: Liu, Jing, et al.
Publicado: (2023)

Susceptibility profile, resistance mechanisms & efficacy ratios of fosfomycin, nitrofurantoin & colistin for carbapenem-resistant Enterobacteriaceae causing urinary tract infections
por: Amladi, Anushree Ulhas, et al.
Publicado: (2019)

1526. Oral Fosfomycin Use for Urinary Tract Infections and Its Clinical Impact on Hospital Stay
por: Mai, Christina, et al.
Publicado: (2018)

A Real-world Study on Prescription Pattern of Fosfomycin in Critical Care Patients
por: Zirpe, Kapil G, et al.
Publicado: (2021)

Correction: Screening and Biosensor-Based Approaches for Lung Cancer Detection. Sensors 2017, 17, 2420
por: Wang, Lulu
Publicado: (2019)

Fosfomycin resistance in community-acquired urinary pathogens from Western Cape, South Africa
por: Mosime, Lesedi B., et al.
Publicado: (2022)

Oral Fosfomycin for the Treatment of Acute and Chronic Bacterial Prostatitis Caused by Multidrug-Resistant Escherichia coli
por: Zhanel, George G., et al.
Publicado: (2018)

Susceptibility of Escherichia coli from Community-Acquired Urinary Tract Infection to Fosfomycin, Nitrofurantoin, and Temocillin in Korea
por: Seo, Mi-Ran, et al.
Publicado: (2014)

Bacterial sensitivity to fosfomycin in pregnant women with urinary infection
por: Souza, Rodrigo Batista, et al.
Publicado: (2015)

Fosfomycin: Pharmacological, Clinical and Future Perspectives
por: Dijkmans, Anneke Corinne, et al.
Publicado: (2017)

1525. Evaluation of Clinical Outcomes With Fosfomycin for E. coli and Non-E. coli Enterobacteriaceae Urinary Tract Infections
por: Lee, Tiffany, et al.
Publicado: (2018)

Effective Treatment for Uncomplicated Urinary Tract Infections with Oral Fosfomycin, Single Center Four Year Retrospective Study
por: Fajfr, Miroslav, et al.
Publicado: (2020)

Fosfomycin vs Ertapenem for Outpatient Treatment of Complicated Urinary Tract Infections: A Multicenter, Retrospective Cohort Study
por: Wald-Dickler, Noah, et al.
Publicado: (2021)

Pharmacokinetic/Pharmacodynamic Analysis of Oral Calcium Fosfomycin: Are Urine Levels Sufficient to Ensure Efficacy for Urinary Tract Infections?
por: Rodríguez-Gascón, Alicia, et al.
Publicado: (2023)

Production of the Excited Charm Mesons D10 (2420) and D2*0(2460) in Z0 Decays
por: CERN. Geneva
Publicado: (1996)

1458. Burden of Illness in Patients with Urinary Tract Infections With or Without Bacteremia Caused by Carbapenem-Resistant Gram-Negative Pathogens in US Hospitals (2014 to 2018)
por: Shields, Ryan K, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b7imm5ob4athcqmqbvt9utd2om